# ServisFirst Bancshares, Inc.: financial statements, quarterly

SFBS · NYSE · CIK 1430723 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sfbs.md) · [Financials](/companies/sfbs/financials.md) · [Filings](/companies/sfbs/filings.md) · [Insiders](/companies/sfbs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sfbs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [114](/filings/0001171843-23-006721.md) | [127 d](/filings/0001171843-24-001111.md) | [124](/filings/0001171843-24-002681.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [8.5](/filings/0001171843-24-006063.md) | [5.2 d](/filings/0001171843-26-001150.md) | [10.6](/filings/0001171843-25-002816.md) | [14.5](/filings/0001171843-25-005039.md) | [12.5](/filings/0001171843-25-006962.md) | [14.2 d](/filings/0001171843-26-001150.md) | [15.9](/filings/0001171843-26-003069.md) | [15.2](/filings/0001171843-26-005359.md) | [13.3](/filings/0001171843-25-006962.md) | [21.2 d](/filings/0001171843-26-001150.md) | [18.0](/filings/0001171843-26-003069.md) | [21.4](/filings/0001171843-26-005359.md) |
| Net income | $m | [53.3](/filings/0001171843-24-006063.md) | [42.1 d](/filings/0001171843-26-001150.md) | [50.0](/filings/0001171843-25-002816.md) | [52.1](/filings/0001171843-25-005039.md) | [59.9](/filings/0001171843-25-006962.md) | [65.2 d](/filings/0001171843-26-001150.md) | [63.2](/filings/0001171843-26-003069.md) | [61.4](/filings/0001171843-26-005359.md) | [65.6](/filings/0001171843-25-006962.md) | [86.4 d](/filings/0001171843-26-001150.md) | [83.0](/filings/0001171843-26-003069.md) | [85.8](/filings/0001171843-26-005359.md) |
| Diluted EPS | $ per share | [0.98](/filings/0001171843-24-006063.md) | not reported | [0.92](/filings/0001171843-25-002816.md) | [0.95](/filings/0001171843-25-005039.md) | [1.10](/filings/0001171843-25-006962.md) | not reported | [1.16](/filings/0001171843-26-003069.md) | [1.12](/filings/0001171843-26-005359.md) | [1.20](/filings/0001171843-25-006962.md) | not reported | [1.52](/filings/0001171843-26-003069.md) | [1.57](/filings/0001171843-26-005359.md) |
| Basic EPS | $ per share | [0.98](/filings/0001171843-24-006063.md) | not reported | [0.92](/filings/0001171843-25-002816.md) | [0.96](/filings/0001171843-25-005039.md) | [1.10](/filings/0001171843-25-006962.md) | not reported | [1.16](/filings/0001171843-26-003069.md) | [1.12](/filings/0001171843-26-005359.md) | [1.20](/filings/0001171843-25-006962.md) | not reported | [1.52](/filings/0001171843-26-003069.md) | [1.57](/filings/0001171843-26-005359.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [16.0](/filings/0001171843-23-006721.md) | [16.1](/filings/0001171843-25-001208.md) | [15.7](/filings/0001171843-24-002681.md) | [16.0](/filings/0001171843-24-004438.md) | [16.4](/filings/0001171843-24-006063.md) | [17.4](/filings/0001171843-26-001150.md) | [18.6](/filings/0001171843-25-002816.md) | [17.4](/filings/0001171843-25-005039.md) | [17.6](/filings/0001171843-25-006962.md) | [17.7](/filings/0001171843-26-005359.md) | [18.2](/filings/0001171843-26-003069.md) | [18.3](/filings/0001171843-26-005359.md) |
| Total liabilities | $bn | [14.6](/filings/0001171843-23-006721.md) | [14.7](/filings/0001171843-25-001208.md) | [14.2](/filings/0001171843-24-002681.md) | [14.5](/filings/0001171843-24-004438.md) | [14.9](/filings/0001171843-24-006063.md) | [15.7](/filings/0001171843-26-001150.md) | [17.0](/filings/0001171843-25-002816.md) | [15.7](/filings/0001171843-25-005039.md) | [15.8](/filings/0001171843-25-006962.md) | [15.9](/filings/0001171843-26-005359.md) | [16.3](/filings/0001171843-26-003069.md) | [16.4](/filings/0001171843-26-005359.md) |
| Shareholders' equity | $bn | [1.4](/filings/0001171843-23-006721.md) | [1.4](/filings/0001171843-25-001208.md) | [1.5](/filings/0001171843-24-002681.md) | [1.5](/filings/0001171843-24-004438.md) | [1.6](/filings/0001171843-24-006063.md) | [1.6](/filings/0001171843-26-001150.md) | [1.7](/filings/0001171843-25-002816.md) | [1.7](/filings/0001171843-25-005039.md) | [1.8](/filings/0001171843-25-006962.md) | [1.8](/filings/0001171843-26-005359.md) | [1.9](/filings/0001171843-26-003069.md) | [2.0](/filings/0001171843-26-005359.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.7 d](/filings/0001171843-24-006063.md) | [91.1 d](/filings/0001171843-26-001150.md) | [53.5](/filings/0001171843-25-002816.md) | [48.3 d](/filings/0001171843-25-005039.md) | [84.0 d](/filings/0001171843-25-006962.md) | [67.2 d](/filings/0001171843-26-001150.md) | [48.0](/filings/0001171843-26-003069.md) | [67.6 d](/filings/0001171843-26-005359.md) | [141 d](/filings/0001171843-25-006962.md) | [98.8 d](/filings/0001171843-26-001150.md) | [70.1](/filings/0001171843-26-003069.md) | [163 d](/filings/0001171843-26-005359.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [0.0 d](/filings/0001171843-24-006063.md) | [15.2 d](/filings/0001171843-26-001150.md) | [16.3](/filings/0001171843-25-002816.md) | [16.4 d](/filings/0001171843-25-005039.md) | [16.4 d](/filings/0001171843-25-006962.md) | [16.4 d](/filings/0001171843-26-001150.md) | [18.3](/filings/0001171843-25-002816.md) | [18.3 d](/filings/0001171843-25-005039.md) | [18.3 d](/filings/0001171843-25-006962.md) | [18.3 d](/filings/0001171843-26-001150.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [54.5](/filings/0001171843-23-006721.md) | [54.5](/filings/0001171843-24-002681.md) | [54.5](/filings/0001171843-24-004438.md) | [54.5](/filings/0001171843-24-006063.md) | [54.6](/filings/0001171843-25-002816.md) | [54.6](/filings/0001171843-25-005039.md) | [54.6](/filings/0001171843-25-006962.md) | [54.7](/filings/0001171843-26-003069.md) | [54.7](/filings/0001171843-26-005359.md) | [54.7](/filings/0001171843-25-006962.md) | [54.7](/filings/0001171843-26-003069.md) | [54.7](/filings/0001171843-26-005359.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 54,672,510 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0001171843-26-005359.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.